News - See what's new!
Find all the latest information on upcoming events, product developments, and company announcements.
A Different Perspective on an Age-Old Disease
OCT utilization in the management of posterior segment diseases has increased significantly in recent years, but are eyecare providers utilizing this tool to its fullest potential?
Read more
Practice Tips for Young Retina Specialists
Priya Vakharia, MD, discusses the importance of staying updated on Heidelberg Engineering technologies, education, and time management tools for efficient retina practices and maintaining good work-life balance.
Read more
Prevent a Time Management Avalanche
The power of technology with Heidelberg Engineering's SPECTRALIS OCT
Read more
International Glaucoma Symposium - 1st February, 2025, University Eye Clinic Mainz, GERMANY
The first International Glaucoma Symposium will be held by Heidelberg Engineering in conjunction with Mainz University on 1st February, 2025, bringing together specialists from around the world.
Read more
The vitreous—remember me?
The article by Jim Williamson, OD, explores the anatomy and function of this lesser-known body and how SPECTRALIS OCT helps monitor for disease or injury.
Read more
Eyewire TV Episode 10.23.2024: Heidelberg SPECTRALIS Flex Module
In this video interview from the 2024 AAO meeting, principal investigator Lejla Vajzovic, MD, explains how the recently FDA-cleared SPECTRALIS Flex Module allows eyecare providers to image patients in a supine position.
Read more
Retinal Oct Scans Pre-Empt Posterior Segment Surprises Following Cataract Surgery
While standard biomicroscopic fundus examinations are commonly used to evaluate the retina, they may miss subtle yet significant macular pathologies, particularly in the presence of lens opacities or poor pupil dilation. By incorporating retinal OCT into preoperative assessments, surgeons can better inform patients, refine surgical strategies, and ultimately enhance postoperative results.
Read more
ASRS 2024: Real-world safety and efficacy of aflibercept 8 mg in the treatment nAMD
Listen to Deepak Sambhara, MD, present the findings from a real-world case study that measured the safety and efficacy of Aflibercept 8 mg for treating nonexudative AMD at ASRS 2024.
Read more
Red and Green Indicators: A New perspective on Glaucoma
Listen in as Dr. Chris Lievens and Dr. Andrew Rixon tackle the complexities and misconceptions of glaucoma care. Their candid discussion emphasizes the importance of looking beyond simplistic interpretations of red and green indicators and committing to a comprehensive analysis to ensure the best possible care.
Read more
Machine learning and AI advances show promise with AMD mapping and tracking
The future of care for AMD shows great promise thanks to enhanced diagnostic imaging and analysis capabilities, as well as customized treatment pathways.
Read more